What is KMDA's relative strength rating?

KMDA ranks at the 83th percentile over 1 month, 63th percentile over 3 months, 39th percentile over 6 months, 62th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is KMDA in?

KMDA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is KMDA in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). KMDA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is KMDA?

KMDA currently shows a 20-day average daily range (ADR%) of 2.9%, a 90-day beta versus the S&P 500 of 0.91. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does KMDA have a seasonal pattern?

TickerStance computes KMDA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what KMDA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did KMDA last report earnings?

No SEC EDGAR filings are linked to KMDA in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Kamada Ltd (KMDA) · RS 39 · Neutral

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Kamada Ltd (KMDA) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.9%, relative volume 1.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month63pctile

6 month39pctile

1 year62pctile

Classic56IBD pctile

LDR71leadership

0 of 5 lenses lit · avg RS pctile 58

!ADR%2.9%✓A/DA!RVOL1.46×!$ Vol$587K

COMPUTED · AS OF 2026-08-24

Pattern read

KMDA is in a stage 1 base, week 2. Currently in a 124-day base; basing ADR 2.4% (broad 2.5%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 15.3% / 8.6%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

1 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

83

3m

63

6m

39

1y

62

LDR

—

StageWeinstein stage analysis

Stage 3 · Topping

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · KMDA

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
KMDA
63RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

CGTXCognition Therapeutics, Inc. Common Stock39 NVAXNovavax Inc39 RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock40 NTLAIntellia Therapeutics, Inc40

§ Seasonality

10y · since 2022

Best monthJan on averageavg +9.67% · 75% win · n 4

Worst monthSep on averageavg -5.77% · 25% win · n 4

KMDA monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	KMDA Jan avg: 9.67% median: 13.61% win: 75% σ: 11.17% n: 4 2022-04-12 → 2026-07-31	KMDA Feb avg: 2.30% median: 3.47% win: 75% σ: 7.38% n: 4 2022-04-12 → 2026-07-31	KMDA Mar avg: -2.91% median: -4.10% win: 25% σ: 7.67% n: 4 2022-04-12 → 2026-07-31	KMDA Apr avg: -3.22% median: -2.40% win: 20% σ: 2.80% n: 5 2022-04-12 → 2026-07-31	KMDA May avg: -1.92% median: 0.96% win: 60% σ: 8.71% n: 5 2022-04-12 → 2026-07-31	KMDA Jun avg: 2.09% median: 0.00% win: 40% σ: 8.75% n: 5 2022-04-12 → 2026-07-31	KMDA Jul avg: 2.75% median: -2.73% win: 40% σ: 10.20% n: 5 2022-04-12 → 2026-07-31	KMDA Aug avg: 2.33% median: -0.48% win: 50% σ: 10.10% n: 4 2022-04-12 → 2026-07-31 (current)	KMDA Sep avg: -5.77% median: -6.87% win: 25% σ: 4.25% n: 4 2022-04-12 → 2026-07-31	KMDA Oct avg: -3.55% median: -0.14% win: 25% σ: 11.96% n: 4 2022-04-12 → 2026-07-31	KMDA Nov avg: 3.87% median: 3.41% win: 75% σ: 6.18% n: 4 2022-04-12 → 2026-07-31	KMDA Dec avg: 5.87% median: 4.38% win: 75% σ: 18.09% n: 4 2022-04-12 → 2026-07-31

ETF OWNERS

ETFs holding KMDA

KMDA appears in 1 ETF as of May 2026: IBBQ at 0.04% weight, $24K notional.

Held by 5 ETFs · $918K across latest filings · largest weight 0.04% (IBBQ).

ETFs holding: 1
Total value: $24K
Top 3 concentration: 100.0%
Max weight: IBBQ · 0.04%

Top 1 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding KMDA ranked by value
ETF	Weight	Value	Δ
IBBQ	0.04%	$24K	—

As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.

Public attention · KMDA

Is the crowd watching?

58/ 100 · vs its own 90-day norm▼ 19 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float31.4Mshares

Shares out57.7Mshares

Market cap$486.4MSmall Cap

FAQ

Frequently asked questions

What is KMDA's relative strength rating?: KMDA ranks at the 83th percentile over 1 month, 63th percentile over 3 months, 39th percentile over 6 months, 62th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is KMDA in?: KMDA is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is KMDA in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). KMDA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is KMDA?: KMDA currently shows a 20-day average daily range (ADR%) of 2.9%, a 90-day beta versus the S&P 500 of 0.91. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does KMDA have a seasonal pattern?: TickerStance computes KMDA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what KMDA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Kamada Ltd (KMDA) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

ETFs holding KMDA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Kamada Ltd (KMDA) — Stance & relative strength

KMDA is not confirmed as a leader. 63 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding KMDA

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?